Taimour Langaee

Taimour Langaee MSPH, Ph.D.

Research Associate Professor

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 273-6357
Business Email: langaee@cop.ufl.edu

About Taimour Langaee

Dr. Langaee is a Research Associate Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and Director of the UF Center for Pharmacogenomics Genotyping Core Laboratory. Before joining the UF faculty in 2002, he completed three years of post-doctoral fellowship in Immunology and Molecular Biology, and Microbiology and Molecular Genetics working on developing HIV vaccine at the College of Medicine University of Montreal and High Density DNA chips for Pseudomonas aeruginosa at the College of Medicine University of Florida.

Dr. Langaee’s research interests are focused on pharmacogenetics (genetic-based variability in drug response) in cardiovascular and auto-immune diseases and developing microarray-based technology methods to facilitate disease diagnosis, genotyping of patients and discovering disease-gene associations.

Research Profile

Dr. Langaee’s research interests are focused on Pharmacogenomics and Personalized Medicine, Development and application of Clinical Diagnostic Genetic Biomarkers, Pharmacogenetics of Dichloroacetate (DCA), Infectious Disease and Microbial Resistance to Beta-lactam antibiotics.

Publications

2018 Drug metabolism and disposition: the biological fate of chemicals
2014 American Journal of Medical Genetics. Part C: Seminars in Medical Genetics
2009 American Journal of Health-System Pharmacy
2008 Molecular Diagnosis and Therapy

Grants

September 2018ACTIVE
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
NATL INST OF HLTH NICHD ·
July 2017ACTIVE
Countering beta-lactam resistance in Pseudomonas aeruginosa
NATL INST OF HLTH NIAID ·
November 2016 – November 2017
Genotyping for the Alpha 2C adrenoreceptor del 322-325 polymorphism.
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Principal Investigator
June 2016 – August 2018
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
NATL INST OF HLTH NICHD ·
July 2015 – June 2017
Countering beta-lactam resistance in Pseudomonas aeruginosa
NATL INST OF HLTH NIAID · Project Manager

Patents

Issued September 2017
Methods and Kits For Predicting Dosing and Improving Safety of Dichloroacetate (DCA)
9,765,393
Published October 2010
Pharmacogenetics for the Identification of Risk Factors for Development of Jaw Osteonrcrosis in Patients on Biphosphonates
US-2011-0166107

Education

1999
Ph.D.
Laval University
1987
M.Sc.
Tehran University of Medical Sciences
1979
B.Sc.
University of Texas at Arlington